Navigation Links
Research and Markets: DNA Sequencing - Technologies, Markets and Companies - 2013
Date:2/21/2013

(PRWEB) February 21, 2013

Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.

Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2012 is described with estimates for 2017 and 2022. Various methods and factors on which market estimates depend are described briefly. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.

The report includes profiles of 108 companies involved in sequencing and their 106 collaborations. The report text is supplemented by 33 tables, 12 figures and 300 selected references to the literature.

Key Topics:

Executive Summary

1. Introduction

2. DNA Sequencing Technologies

3. Comparative Analysis of Sequencing Technologies

4. Sequencing for Research

5. Applications of Sequencing in Healthcare

6. Markets for Sequencers

7. Companies Involved in Sequencing

8. References

For more information visit http://www.researchandmarkets.com/research/l6kzx6/dna_sequencing

Research and Markets
Laura Wood, Senior Manager,
press (at) researchandmarkets (dot) com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Read the full story at http://www.prweb.com/releases/2013/2/prweb10449772.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Research and Markets: Biologics in the Emerging Markets: Ripe for Realization of the Commercial Potential - But Hurdles Still to Overcome
2. Research and Markets: Nanobiotechnology Applications, Markets and Companies - 2013 Report
3. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
4. GoLIMS Technology Speeds and Safeguards Alltechs Global Research
5. QIAGEN Unveils Sample-to-Result Next-Generation Sequencing Workflow Designed for Clinical Research and Diagnostics
6. Anonymous survey launched for Parkinson’s patients to collect data for research to help determine the cause of Parkinson's disease.
7. Todays Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals
8. Florida Tech Research Team Earns Competitive Grant, Begins ISS Mission Biology Experiment
9. Researchers create semiconductor nano-shish-kebabs with potential for 3-D technologies
10. Research and Markets: Cytogenetics - Technologies, Markets and Companies - 2013
11. Research and Markets: Transdermal Drug Delivery - Technologies, Markets, and Companies - 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2017)...  Trianni, Inc. („TRIANNI") gab heute bekannt, man ... über die Verwendung der The Trianni Mouse unterschrieben, ... Entdeckung monoklonaler Antikörper. Die Trianni Plattform ... das Janssen den Zugang zu einer ... für die schelle Isolierung vollständig menschlicher Therapeutika optimiert ...
(Date:2/15/2017)... 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), ... fourth quarter and full year ended December 31, ... for Vanda as we continued to demonstrate strong ... exclusivity for Fanapt," said Mihael H. Polymeropoulos, M.D., ... pipeline with important 2017 milestones underscores Vanda,s commitment ...
(Date:2/15/2017)... Feb. 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, will ... presentation) at 8:00 AM EST on Thursday, February 16, ... clinical program, the recently announced closing of a $10.5 ... To participate in the live call and ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health ... Diameter Health technology in the hands of Lantana analysts. The high-performance platform of ... and public health entities – all those mining value from clinical data – ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):